Venous thromboembolic disease and hematologic considerations in obesity.
Venous thromboembolic disease continues to be a major source of morbidity and mortality, with obese patients who are critically ill presenting some of the most at-risk patients. As the literature evolves, it has become clear that there is a complex relationship between obesity and thrombosis and atherogenesis. It is true that many of these conditions are reversible with weight loss; however, obesity remains on the rise. Management of obese patients must incorporate and consider these intricate changes in an attempt to improve patient outcomes.
Division of Critical Care Medicine, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA 17822, USA.
Mitchell K
MK
Craft
Mary Jane
MJ
Reed
D016638:Critical Illness; D006801:Humans; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology*; D011655:Pulmonary Embolism / Q000150:complications* / Q000503:physiopathology; D054556:Venous Thromboembolism / Q000150:complications* / Q000503:physiopathology; D020246:Venous Thrombosis / Q000150:complications*